http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2025, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 14 Apr 2025 08:04:58 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Corporate+News/Longevity+Health+Holdings+%28XAGE%29+Executes+Merger+Agreement+With+2020+Biolabs/24633782.html <p>Longevity Health Holdings, Inc. (Nasdaq: XAGE), a company focused on human longevity and healthy aging through technologically innovative and clinically proven products in regenerative bio-aesthetics, diagnostics, and nutrition (“Longevity”, the “Company”, “we”, “our”, or “us”), today announced the execution of a merger agreement (the “Merger”) with 20/20 BioLabs, Inc. (“20/20”), a leading provider of innovative laboratory tests for the early detection and the proactive management of chronic disease risk, to combine the companies in an all-stock transaction. Following the closing of the Merger (the “Closing”), the combined company is expected to continue to trade on Nasdaq under the symbol “XAGE.”</p><p http://www.streetinsider.com/Corporate+News/Longevity+Health+Holdings+%28XAGE%29+Executes+Merger+Agreement+With+2020+Biolabs/24633782.html Mon, 14 Apr 2025 08:04:58 -0400 XAGE XAGEW http://www.streetinsider.com/Corporate+News/Longevity+Health+Holdings+%28XAGE%29+Executes+Merger+Agreement+With+2020+Biolabs/24633782.html <p>Longevity Health Holdings, Inc. (Nasdaq: XAGE), a company focused on human longevity and healthy aging through technologically innovative and clinically proven products in regenerative bio-aesthetics, diagnostics, and nutrition (“Longevity”, the “Company”, “we”, “our”, or “us”), today announced the execution of a merger agreement (the “Merger”) with 20/20 BioLabs, Inc. (“20/20”), a leading provider of innovative laboratory tests for the early detection and the proactive management of chronic disease risk, to combine the companies in an all-stock transaction. Following the closing of the Merger (the “Closing”), the combined company is expected to continue to trade on Nasdaq under the symbol “XAGE.”</p><p http://www.streetinsider.com/Corporate+News/Longevity+Health+Holdings+%28XAGE%29+Executes+Merger+Agreement+With+2020+Biolabs/24633782.html Mon, 14 Apr 2025 08:04:58 -0400 XAGE XAGEW http://www.streetinsider.com/Mergers+and+Acquisitions/Longevity+Health+Holdings+%28XAGE%29+Executes+Merger+Agreement+With+2020+Biolabs/24633782.html <p>Longevity Health Holdings, Inc. (Nasdaq: XAGE), a company focused on human longevity and healthy aging through technologically innovative and clinically proven products in regenerative bio-aesthetics, diagnostics, and nutrition (“Longevity”, the “Company”, “we”, “our”, or “us”), today announced the execution of a merger agreement (the “Merger”) with 20/20 BioLabs, Inc. (“20/20”), a leading provider of innovative laboratory tests for the early detection and the proactive management of chronic disease risk, to combine the companies in an all-stock transaction. Following the closing of the Merger (the “Closing”), the combined company is expected to continue to trade on Nasdaq under the symbol “XAGE.”</p><p http://www.streetinsider.com/Mergers+and+Acquisitions/Longevity+Health+Holdings+%28XAGE%29+Executes+Merger+Agreement+With+2020+Biolabs/24633782.html Mon, 14 Apr 2025 08:04:58 -0400 XAGE XAGEW http://www.streetinsider.com/Mergers+and+Acquisitions/Longevity+Health+Holdings+%28XAGE%29+Executes+Merger+Agreement+With+2020+Biolabs/24633782.html <p>Longevity Health Holdings, Inc. (Nasdaq: XAGE), a company focused on human longevity and healthy aging through technologically innovative and clinically proven products in regenerative bio-aesthetics, diagnostics, and nutrition (“Longevity”, the “Company”, “we”, “our”, or “us”), today announced the execution of a merger agreement (the “Merger”) with 20/20 BioLabs, Inc. (“20/20”), a leading provider of innovative laboratory tests for the early detection and the proactive management of chronic disease risk, to combine the companies in an all-stock transaction. Following the closing of the Merger (the “Closing”), the combined company is expected to continue to trade on Nasdaq under the symbol “XAGE.”</p><p http://www.streetinsider.com/Mergers+and+Acquisitions/Longevity+Health+Holdings+%28XAGE%29+Executes+Merger+Agreement+With+2020+Biolabs/24633782.html Mon, 14 Apr 2025 08:04:58 -0400 XAGE XAGEW http://www.streetinsider.com/Press+Releases/Longevity+Health+Holdings+Announces+Execution+of+Merger+Agreement+With+2020+Biolabs/24633778.html <p align="justify">PITTSBURGH, Pa. &amp; GAITHERSBURG, Md., April 14, 2025 (GLOBE NEWSWIRE) -- Longevity Health Holdings, Inc. (Nasdaq: XAGE), a company focused on human longevity and healthy aging through technologically innovative and clinically proven products in regenerative bio-aesthetics, diagnostics, and nutrition (“Longevity”, the “Company”, “we”, “our”, or “us”), today announced the execution of a merger agreement (the “Merger”) with 20/20 BioLabs, Inc. (“20/20”), a leading provider of innovative laboratory tests for the early detection and the proactive management of chronic disease risk, to combine the companies in an all-stock transaction. Following the closing of the Merger (the “Closing”), the http://www.streetinsider.com/Press+Releases/Longevity+Health+Holdings+Announces+Execution+of+Merger+Agreement+With+2020+Biolabs/24633778.html Mon, 14 Apr 2025 08:03:00 -0400 A.09642568 A.17921544 O.01689360 O.20371933 O.51065182 XAGE XAGEW http://www.streetinsider.com/Press+Releases/Longevity+Health+Holdings+Announces+Execution+of+Merger+Agreement+With+2020+Biolabs/24633778.html <p align="justify">PITTSBURGH, Pa. &amp; GAITHERSBURG, Md., April 14, 2025 (GLOBE NEWSWIRE) -- Longevity Health Holdings, Inc. (Nasdaq: XAGE), a company focused on human longevity and healthy aging through technologically innovative and clinically proven products in regenerative bio-aesthetics, diagnostics, and nutrition (“Longevity”, the “Company”, “we”, “our”, or “us”), today announced the execution of a merger agreement (the “Merger”) with 20/20 BioLabs, Inc. (“20/20”), a leading provider of innovative laboratory tests for the early detection and the proactive management of chronic disease risk, to combine the companies in an all-stock transaction. Following the closing of the Merger (the “Closing”), the http://www.streetinsider.com/Press+Releases/Longevity+Health+Holdings+Announces+Execution+of+Merger+Agreement+With+2020+Biolabs/24633778.html Mon, 14 Apr 2025 08:03:00 -0400 A.09642568 A.17921544 O.01689360 O.20371933 O.51065182 XAGE XAGEW http://www.streetinsider.com/Press+Releases/Longevity+Health+Holdings+Announces+Execution+of+Merger+Agreement+With+2020+Biolabs/24633778.html <p align="justify">PITTSBURGH, Pa. &amp; GAITHERSBURG, Md., April 14, 2025 (GLOBE NEWSWIRE) -- Longevity Health Holdings, Inc. (Nasdaq: XAGE), a company focused on human longevity and healthy aging through technologically innovative and clinically proven products in regenerative bio-aesthetics, diagnostics, and nutrition (“Longevity”, the “Company”, “we”, “our”, or “us”), today announced the execution of a merger agreement (the “Merger”) with 20/20 BioLabs, Inc. (“20/20”), a leading provider of innovative laboratory tests for the early detection and the proactive management of chronic disease risk, to combine the companies in an all-stock transaction. Following the closing of the Merger (the “Closing”), the http://www.streetinsider.com/Press+Releases/Longevity+Health+Holdings+Announces+Execution+of+Merger+Agreement+With+2020+Biolabs/24633778.html Mon, 14 Apr 2025 08:03:00 -0400 A.09642568 A.17921544 O.01689360 O.20371933 O.51065182 XAGE XAGEW http://www.streetinsider.com/Press+Releases/Longevity+Health+Holdings+Announces+Execution+of+Merger+Agreement+With+2020+Biolabs/24633778.html <p align="justify">PITTSBURGH, Pa. &amp; GAITHERSBURG, Md., April 14, 2025 (GLOBE NEWSWIRE) -- Longevity Health Holdings, Inc. (Nasdaq: XAGE), a company focused on human longevity and healthy aging through technologically innovative and clinically proven products in regenerative bio-aesthetics, diagnostics, and nutrition (“Longevity”, the “Company”, “we”, “our”, or “us”), today announced the execution of a merger agreement (the “Merger”) with 20/20 BioLabs, Inc. (“20/20”), a leading provider of innovative laboratory tests for the early detection and the proactive management of chronic disease risk, to combine the companies in an all-stock transaction. Following the closing of the Merger (the “Closing”), the http://www.streetinsider.com/Press+Releases/Longevity+Health+Holdings+Announces+Execution+of+Merger+Agreement+With+2020+Biolabs/24633778.html Mon, 14 Apr 2025 08:03:00 -0400 A.09642568 A.17921544 O.01689360 O.20371933 O.51065182 XAGE XAGEW http://www.streetinsider.com/Press+Releases/Longevity+Health+Holdings+Announces+Execution+of+Merger+Agreement+With+2020+Biolabs/24633778.html <p align="justify">PITTSBURGH, Pa. &amp; GAITHERSBURG, Md., April 14, 2025 (GLOBE NEWSWIRE) -- Longevity Health Holdings, Inc. (Nasdaq: XAGE), a company focused on human longevity and healthy aging through technologically innovative and clinically proven products in regenerative bio-aesthetics, diagnostics, and nutrition (“Longevity”, the “Company”, “we”, “our”, or “us”), today announced the execution of a merger agreement (the “Merger”) with 20/20 BioLabs, Inc. (“20/20”), a leading provider of innovative laboratory tests for the early detection and the proactive management of chronic disease risk, to combine the companies in an all-stock transaction. Following the closing of the Merger (the “Closing”), the http://www.streetinsider.com/Press+Releases/Longevity+Health+Holdings+Announces+Execution+of+Merger+Agreement+With+2020+Biolabs/24633778.html Mon, 14 Apr 2025 08:03:00 -0400 A.09642568 A.17921544 O.01689360 O.20371933 O.51065182 XAGE XAGEW http://www.streetinsider.com/Press+Releases/Longevity+Health+Holdings+Announces+Execution+of+Merger+Agreement+With+2020+Biolabs/24633778.html <p align="justify">PITTSBURGH, Pa. &amp; GAITHERSBURG, Md., April 14, 2025 (GLOBE NEWSWIRE) -- Longevity Health Holdings, Inc. (Nasdaq: XAGE), a company focused on human longevity and healthy aging through technologically innovative and clinically proven products in regenerative bio-aesthetics, diagnostics, and nutrition (“Longevity”, the “Company”, “we”, “our”, or “us”), today announced the execution of a merger agreement (the “Merger”) with 20/20 BioLabs, Inc. (“20/20”), a leading provider of innovative laboratory tests for the early detection and the proactive management of chronic disease risk, to combine the companies in an all-stock transaction. Following the closing of the Merger (the “Closing”), the http://www.streetinsider.com/Press+Releases/Longevity+Health+Holdings+Announces+Execution+of+Merger+Agreement+With+2020+Biolabs/24633778.html Mon, 14 Apr 2025 08:03:00 -0400 A.09642568 A.17921544 O.01689360 O.20371933 O.51065182 XAGE XAGEW http://www.streetinsider.com/Press+Releases/Longevity+Health+Holdings+Announces+Execution+of+Merger+Agreement+With+2020+Biolabs/24633778.html <p align="justify">PITTSBURGH, Pa. &amp; GAITHERSBURG, Md., April 14, 2025 (GLOBE NEWSWIRE) -- Longevity Health Holdings, Inc. (Nasdaq: XAGE), a company focused on human longevity and healthy aging through technologically innovative and clinically proven products in regenerative bio-aesthetics, diagnostics, and nutrition (“Longevity”, the “Company”, “we”, “our”, or “us”), today announced the execution of a merger agreement (the “Merger”) with 20/20 BioLabs, Inc. (“20/20”), a leading provider of innovative laboratory tests for the early detection and the proactive management of chronic disease risk, to combine the companies in an all-stock transaction. Following the closing of the Merger (the “Closing”), the http://www.streetinsider.com/Press+Releases/Longevity+Health+Holdings+Announces+Execution+of+Merger+Agreement+With+2020+Biolabs/24633778.html Mon, 14 Apr 2025 08:03:00 -0400 A.09642568 A.17921544 O.01689360 O.20371933 O.51065182 XAGE XAGEW http://www.streetinsider.com/Globe+Newswire/Longevity+Health+Holdings+Announces+Execution+of+Merger+Agreement+With+2020+Biolabs/24633778.html <p align="justify">PITTSBURGH, Pa. &amp; GAITHERSBURG, Md., April 14, 2025 (GLOBE NEWSWIRE) -- Longevity Health Holdings, Inc. (Nasdaq: XAGE), a company focused on human longevity and healthy aging through technologically innovative and clinically proven products in regenerative bio-aesthetics, diagnostics, and nutrition (“Longevity”, the “Company”, “we”, “our”, or “us”), today announced the execution of a merger agreement (the “Merger”) with 20/20 BioLabs, Inc. (“20/20”), a leading provider of innovative laboratory tests for the early detection and the proactive management of chronic disease risk, to combine the companies in an all-stock transaction. Following the closing of the Merger (the “Closing”), the http://www.streetinsider.com/Globe+Newswire/Longevity+Health+Holdings+Announces+Execution+of+Merger+Agreement+With+2020+Biolabs/24633778.html Mon, 14 Apr 2025 08:03:00 -0400 A.09642568 A.17921544 O.01689360 O.20371933 O.51065182 XAGE XAGEW http://www.streetinsider.com/Globe+Newswire/Longevity+Health+Holdings+Announces+Execution+of+Merger+Agreement+With+2020+Biolabs/24633778.html <p align="justify">PITTSBURGH, Pa. &amp; GAITHERSBURG, Md., April 14, 2025 (GLOBE NEWSWIRE) -- Longevity Health Holdings, Inc. (Nasdaq: XAGE), a company focused on human longevity and healthy aging through technologically innovative and clinically proven products in regenerative bio-aesthetics, diagnostics, and nutrition (“Longevity”, the “Company”, “we”, “our”, or “us”), today announced the execution of a merger agreement (the “Merger”) with 20/20 BioLabs, Inc. (“20/20”), a leading provider of innovative laboratory tests for the early detection and the proactive management of chronic disease risk, to combine the companies in an all-stock transaction. Following the closing of the Merger (the “Closing”), the http://www.streetinsider.com/Globe+Newswire/Longevity+Health+Holdings+Announces+Execution+of+Merger+Agreement+With+2020+Biolabs/24633778.html Mon, 14 Apr 2025 08:03:00 -0400 A.09642568 A.17921544 O.01689360 O.20371933 O.51065182 XAGE XAGEW http://www.streetinsider.com/Globe+Newswire/Longevity+Health+Holdings+Announces+Execution+of+Merger+Agreement+With+2020+Biolabs/24633778.html <p align="justify">PITTSBURGH, Pa. &amp; GAITHERSBURG, Md., April 14, 2025 (GLOBE NEWSWIRE) -- Longevity Health Holdings, Inc. (Nasdaq: XAGE), a company focused on human longevity and healthy aging through technologically innovative and clinically proven products in regenerative bio-aesthetics, diagnostics, and nutrition (“Longevity”, the “Company”, “we”, “our”, or “us”), today announced the execution of a merger agreement (the “Merger”) with 20/20 BioLabs, Inc. (“20/20”), a leading provider of innovative laboratory tests for the early detection and the proactive management of chronic disease risk, to combine the companies in an all-stock transaction. Following the closing of the Merger (the “Closing”), the http://www.streetinsider.com/Globe+Newswire/Longevity+Health+Holdings+Announces+Execution+of+Merger+Agreement+With+2020+Biolabs/24633778.html Mon, 14 Apr 2025 08:03:00 -0400 A.09642568 A.17921544 O.01689360 O.20371933 O.51065182 XAGE XAGEW http://www.streetinsider.com/Globe+Newswire/Longevity+Health+Holdings+Announces+Execution+of+Merger+Agreement+With+2020+Biolabs/24633778.html <p align="justify">PITTSBURGH, Pa. &amp; GAITHERSBURG, Md., April 14, 2025 (GLOBE NEWSWIRE) -- Longevity Health Holdings, Inc. (Nasdaq: XAGE), a company focused on human longevity and healthy aging through technologically innovative and clinically proven products in regenerative bio-aesthetics, diagnostics, and nutrition (“Longevity”, the “Company”, “we”, “our”, or “us”), today announced the execution of a merger agreement (the “Merger”) with 20/20 BioLabs, Inc. (“20/20”), a leading provider of innovative laboratory tests for the early detection and the proactive management of chronic disease risk, to combine the companies in an all-stock transaction. Following the closing of the Merger (the “Closing”), the http://www.streetinsider.com/Globe+Newswire/Longevity+Health+Holdings+Announces+Execution+of+Merger+Agreement+With+2020+Biolabs/24633778.html Mon, 14 Apr 2025 08:03:00 -0400 A.09642568 A.17921544 O.01689360 O.20371933 O.51065182 XAGE XAGEW http://www.streetinsider.com/Globe+Newswire/Longevity+Health+Holdings+Announces+Execution+of+Merger+Agreement+With+2020+Biolabs/24633778.html <p align="justify">PITTSBURGH, Pa. &amp; GAITHERSBURG, Md., April 14, 2025 (GLOBE NEWSWIRE) -- Longevity Health Holdings, Inc. (Nasdaq: XAGE), a company focused on human longevity and healthy aging through technologically innovative and clinically proven products in regenerative bio-aesthetics, diagnostics, and nutrition (“Longevity”, the “Company”, “we”, “our”, or “us”), today announced the execution of a merger agreement (the “Merger”) with 20/20 BioLabs, Inc. (“20/20”), a leading provider of innovative laboratory tests for the early detection and the proactive management of chronic disease risk, to combine the companies in an all-stock transaction. Following the closing of the Merger (the “Closing”), the http://www.streetinsider.com/Globe+Newswire/Longevity+Health+Holdings+Announces+Execution+of+Merger+Agreement+With+2020+Biolabs/24633778.html Mon, 14 Apr 2025 08:03:00 -0400 A.09642568 A.17921544 O.01689360 O.20371933 O.51065182 XAGE XAGEW http://www.streetinsider.com/Globe+Newswire/Longevity+Health+Holdings+Announces+Execution+of+Merger+Agreement+With+2020+Biolabs/24633778.html <p align="justify">PITTSBURGH, Pa. &amp; GAITHERSBURG, Md., April 14, 2025 (GLOBE NEWSWIRE) -- Longevity Health Holdings, Inc. (Nasdaq: XAGE), a company focused on human longevity and healthy aging through technologically innovative and clinically proven products in regenerative bio-aesthetics, diagnostics, and nutrition (“Longevity”, the “Company”, “we”, “our”, or “us”), today announced the execution of a merger agreement (the “Merger”) with 20/20 BioLabs, Inc. (“20/20”), a leading provider of innovative laboratory tests for the early detection and the proactive management of chronic disease risk, to combine the companies in an all-stock transaction. Following the closing of the Merger (the “Closing”), the http://www.streetinsider.com/Globe+Newswire/Longevity+Health+Holdings+Announces+Execution+of+Merger+Agreement+With+2020+Biolabs/24633778.html Mon, 14 Apr 2025 08:03:00 -0400 A.09642568 A.17921544 O.01689360 O.20371933 O.51065182 XAGE XAGEW http://www.streetinsider.com/Globe+Newswire/Longevity+Health+Holdings+Announces+Execution+of+Merger+Agreement+With+2020+Biolabs/24633778.html <p align="justify">PITTSBURGH, Pa. &amp; GAITHERSBURG, Md., April 14, 2025 (GLOBE NEWSWIRE) -- Longevity Health Holdings, Inc. (Nasdaq: XAGE), a company focused on human longevity and healthy aging through technologically innovative and clinically proven products in regenerative bio-aesthetics, diagnostics, and nutrition (“Longevity”, the “Company”, “we”, “our”, or “us”), today announced the execution of a merger agreement (the “Merger”) with 20/20 BioLabs, Inc. (“20/20”), a leading provider of innovative laboratory tests for the early detection and the proactive management of chronic disease risk, to combine the companies in an all-stock transaction. Following the closing of the Merger (the “Closing”), the http://www.streetinsider.com/Globe+Newswire/Longevity+Health+Holdings+Announces+Execution+of+Merger+Agreement+With+2020+Biolabs/24633778.html Mon, 14 Apr 2025 08:03:00 -0400 A.09642568 A.17921544 O.01689360 O.20371933 O.51065182 XAGE XAGEW